Culbertson A N & Co’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.2M Buy
1,040
+5
+0.5% +$5.9K 0.14% 96
2026
Q2
$1.24M Buy
1,035
+155
+18% +$158K 0.14% 94
2026
Q1
$809K Hold
880
– – 0.11% 101
2025
Q4
$946K Hold
880
– – 0.13% 94
2025
Q3
$671K Buy
880
+4
+0.5% +$2.98K 0.1% 101
2025
Q2
$683K Buy
876
+123
+16% +$95.6K 0.1% 101
2025
Q1
$622K Buy
753
+441
+141% +$367K 0.1% 103
2024
Q4
$241K Sell
312
-72
-19% -$59.6K 0.04% 123
2024
Q3
$340K Sell
384
-5
-1% -$4.5K 0.05% 114
2024
Q2
$352K Sell
389
-14
-3% -$11.2K 0.06% 110
2024
Q1
$314K Hold
403
– – 0.05% 111
2023
Q4
$235K Hold
403
– – 0.04% 117
2023
Q3
$216K Buy
+403
New +$208K 0.04% 114

Other funds holding LLY

Culbertson A N & Co's LLY Position: Q3 2026 in Review

Culbertson A N & Co increased its Eli Lilly (LLY) stake by 0.48% in Q3 2026, buying an estimated $5.9K and bringing the position to 1,040 shares worth $1.2M. The position accounts for 0.14% of the portfolio, ranked #96.

Culbertson A N & Co first reported a position in LLY in Q3 2023 and has held it in 13 quarters since. The position peaked at $1.24M in Q2 2026. 2,846 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Culbertson A N & Co held 1,040 shares of Eli Lilly worth $1.2M as of Q3 2026.
  • Culbertson A N & Co bought 5 Eli Lilly shares in Q3 2026, an estimated $5.9K.
  • Eli Lilly made up 0.14% of Culbertson A N & Co's portfolio in Q3 2026, its #96 holding.
  • Culbertson A N & Co first reported a position in Eli Lilly in Q3 2023 and has held it in 13 quarters since.
  • Culbertson A N & Co's Eli Lilly position peaked at $1.24M in Q2 2026.
  • 2,846 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Culbertson A N & Co's 13F filing for Q3 2026, filed 21 Oct 2026.